Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nice Ltd

153.41
-0.8600-0.56%
Post-market: 153.500.0900+0.06%19:44 EDT
Volume:295.15K
Turnover:45.12M
Market Cap:9.70B
PE:21.40
High:154.23
Open:154.23
Low:151.80
Close:154.27
Loading ...

NICE Ltd. (NICE): Among Billionaire George Soros’ Small-Cap Stocks with Huge Upside Potential

Insider Monkey
·
24 Apr

NICE Is Maintained at Buy by Rosenblatt

Dow Jones
·
24 Apr

Pharming Group’s Joenja® Receives NICE Recommendation for APDS Treatment

TIPRANKS
·
23 Apr

Pharming announces positive recommendation from NICE for Joenja

TIPRANKS
·
23 Apr

Pharming Group’s Strategic Expansion and NICE Endorsement Drive Buy Rating

TIPRANKS
·
23 Apr

NICE Named Leader In 2025 Aragon Research GlobeTM for AI Agent Platforms in the Intelligent Contact Center

Business Wire
·
17 Apr

NICE Is Maintained at Buy by DA Davidson

Dow Jones
·
15 Apr

Nice price target lowered to $180 from $200 at DA Davidson

TIPRANKS
·
14 Apr

Is NICE Ltd. (NICE) the Best Big Data Stock to Buy According to Analysts?

Insider Monkey
·
09 Apr

NICE Actimize Recognized as a Leader in Anti-Money Laundering Solutions Report with Highest Scores Possible in All Ten Criteria within Current Offering Category

Business Wire
·
08 Apr

Hidalgo County Criminal District Attorney’s Office Digitally Transforms Evidence Management with NICE Justice

Business Wire
·
03 Apr

NICE Actimize X-Sight ActOne Platform Redefines Financial Crime Investigations with Agentic AI

Business Wire
·
02 Apr

Will the Market Embrace Elevated Multiples for NICE Ltd. (NICE)?

Insider Monkey
·
31 Mar

OS Therapies Provides Regulatory Update on Rare Pediatric Cancer Immunotherapy Candidate OST-HER2 for Human Osteosarcoma

Business Wire
·
31 Mar

IMFINZI® (durvalumab) approved in the US as first and only perioperative immunotherapy for patients with muscle-invasive bladder cancer

Business Wire
·
31 Mar

GE HealthCare unveils Revolution™ Vibe CT system with Unlimited One-Beat Cardiac imaging and AI Solutions

Business Wire
·
29 Mar

NICE Actimize 2025 EMEA Fraud Survey Uncovers the Top Financial Fraud Types That FIs Must Prioritize

Business Wire
·
26 Mar

NICE Ltd. (NICE) Launches CXone Mpower Orchestrator for AI-Driven Customer Service

Insider Monkey
·
23 Mar

Press Release: Autolus Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

Dow Jones
·
20 Mar

NICE Price Target Maintained With a $200.00/Share by RBC Capital

Dow Jones
·
19 Mar